These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21310403)

  • 81. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children.
    Grandjean P; Budtz-Jørgensen E
    Environ Health; 2013 Apr; 12(1):35. PubMed ID: 23597293
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study.
    Pop VJ; Brouwers EP; Vader HL; Vulsma T; van Baar AL; de Vijlder JJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):282-8. PubMed ID: 12919150
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks.
    Grandjean P; Clapp R
    New Solut; 2015 Aug; 25(2):147-63. PubMed ID: 26084549
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Exposure of Pregnant Mice to Perfluorobutanesulfonate Causes Hypothyroxinemia and Developmental Abnormalities in Female Offspring.
    Feng X; Cao X; Zhao S; Wang X; Hua X; Chen L; Chen L
    Toxicol Sci; 2017 Feb; 155(2):409-419. PubMed ID: 27803384
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth Cohort.
    Bonefeld-Jørgensen EC; Long M; Fredslund SO; Bossi R; Olsen J
    Cancer Causes Control; 2014 Nov; 25(11):1439-48. PubMed ID: 25148915
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women.
    Tsai MS; Chang SH; Kuo WH; Kuo CH; Li SY; Wang MY; Chang DY; Lu YS; Huang CS; Cheng AL; Lin CH; Chen PC
    Environ Int; 2020 Sep; 142():105850. PubMed ID: 32580117
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Maternal cognitive function during pregnancy in relation to hypo- and hyperthyroxinemia.
    Pop VJ; Ormindean V; Mocan A; Meems M; Broeren M; Denollet JK; Wiersinga WM; Bunevicius A
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):824-833. PubMed ID: 31614008
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thyroid Disrupting Effects of Old and New Generation PFAS.
    Coperchini F; Croce L; Ricci G; Magri F; Rotondi M; Imbriani M; Chiovato L
    Front Endocrinol (Lausanne); 2020; 11():612320. PubMed ID: 33542707
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prenatal exposure to perfluorinated compounds affects thyroid hormone levels in newborn girls.
    Shah-Kulkarni S; Kim BM; Hong YC; Kim HS; Kwon EJ; Park H; Kim YJ; Ha EH
    Environ Int; 2016 Sep; 94():607-613. PubMed ID: 27395336
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Perfluorooctanoic acid alters progesterone activity in human endometrial cells and induces reproductive alterations in young women.
    Di Nisio A; Rocca MS; Sabovic I; De Rocco Ponce M; Corsini C; Guidolin D; Zanon C; Acquasaliente L; Carosso AR; De Toni L; Foresta C
    Chemosphere; 2020 Mar; 242():125208. PubMed ID: 31896193
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Implications of early menopause in women exposed to perfluorocarbons.
    Knox SS; Jackson T; Javins B; Frisbee SJ; Shankar A; Ducatman AM
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1747-53. PubMed ID: 21411548
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.
    Ammitzbøll C; Börnsen L; Petersen ER; Oturai AB; Søndergaard HB; Grandjean P; Sellebjerg F
    J Neuroimmunol; 2019 May; 330():90-95. PubMed ID: 30852181
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA).
    Convertino M; Church TR; Olsen GW; Liu Y; Doyle E; Elcombe CR; Barnett AL; Samuel LM; MacPherson IR; Evans TRJ
    Toxicol Sci; 2018 May; 163(1):293-306. PubMed ID: 29462473
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project.
    Knox SS; Jackson T; Frisbee SJ; Javins B; Ducatman AM
    J Toxicol Sci; 2011 Aug; 36(4):403-10. PubMed ID: 21804304
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Bayesian adjustment for measurement error in continuous exposures in an individually matched case-control study.
    Espino-Hernandez G; Gustafson P; Burstyn I
    BMC Med Res Methodol; 2011 May; 11():67. PubMed ID: 21569573
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The pollutant perfluorohexane sulfonate (PFHxS) reduces serum thyroxine but does not alter thyroid action in the postnatal rat brain.
    O'Shaughnessy KL; Bell KS; Sasser AL; Gilbert ME; Riutta C; Ford JL; McCord J; Wood CR
    Environ Int; 2024 Jun; 190():108838. PubMed ID: 38963985
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Truth in the Serum? Estimating PFAS Relative Potency for Human Risk Assessment.
    Schmidt S
    Environ Health Perspect; 2022 Sep; 130(9):94001. PubMed ID: 36129438
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Potential Risk Factors for Isolated Hypothyroxinemia in Women of Childbearing Age-Results from Retrospective Analysis.
    Karbownik-Lewińska M; Stępniak J; Lewiński A
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830664
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Doubts and Concerns about Isolated Maternal Hypothyroxinemia.
    Moleti M; Trimarchi F; Vermiglio F
    J Thyroid Res; 2011; 2011():463029. PubMed ID: 21765991
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.